Cargando…
Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147
ABSTRACT: Lacticin 3147 is a dual-acting two-peptide bacteriocin which is generally active against Gram-positive bacteria, including Listeria monocytogenes and antimicrobial-resistant bacteria such as Closteroides difficile in the colon. L. monocytogenes infections can cause life-long effects in the...
Autores principales: | Ryan, Aoibhín, Patel, Pratikkumar, O’Connor, Paula M., Ross, R. Paul, Hill, Colin, Hudson, Sarah P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236048/ https://www.ncbi.nlm.nih.gov/pubmed/33876405 http://dx.doi.org/10.1007/s13346-021-00984-9 |
Ejemplares similares
-
The development of a solid lipid nanoparticle (SLN)-based lacticin 3147 hydrogel for the treatment of wound infections
por: Ryan, Aoibhín, et al.
Publicado: (2023) -
Manipulation of charged residues within the two‐peptide lantibiotic lacticin 3147
por: Deegan, Lucy H., et al.
Publicado: (2010) -
Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
por: O'Connor, Eileen B, et al.
Publicado: (2007) -
Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147
por: Crispie, Fiona, et al.
Publicado: (2004) -
The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
por: Draper, Lorraine A, et al.
Publicado: (2013)